147 related articles for article (PubMed ID: 17870090)
1. Structural insight into the constitutive repression function of the nuclear receptor Rev-erbbeta.
Woo EJ; Jeong DG; Lim MY; Jun Kim S; Kim KJ; Yoon SM; Park BC; Ryu SE
J Mol Biol; 2007 Oct; 373(3):735-44. PubMed ID: 17870090
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha.
Xu HE; Stanley TB; Montana VG; Lambert MH; Shearer BG; Cobb JE; McKee DD; Galardi CM; Plunket KD; Nolte RT; Parks DJ; Moore JT; Kliewer SA; Willson TM; Stimmel JB
Nature; 2002 Feb; 415(6873):813-7. PubMed ID: 11845213
[TBL] [Abstract][Full Text] [Related]
3. Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains.
Renaud JP; Harris JM; Downes M; Burke LJ; Muscat GE
Mol Endocrinol; 2000 May; 14(5):700-17. PubMed ID: 10809233
[TBL] [Abstract][Full Text] [Related]
4. The orphan nuclear receptor Rev-erbbeta recruits Tip60 and HDAC1 to regulate apolipoprotein CIII promoter.
Wang J; Liu N; Liu Z; Li Y; Song C; Yuan H; Li YY; Zhao X; Lu H
Biochim Biophys Acta; 2008 Feb; 1783(2):224-36. PubMed ID: 17996965
[TBL] [Abstract][Full Text] [Related]
5. Role of Rev-erbα domains for transactivation of the connexin43 promoter with Sp1.
Negoro H; Okinami T; Kanematsu A; Imamura M; Tabata Y; Ogawa O
FEBS Lett; 2013 Jan; 587(1):98-103. PubMed ID: 23201262
[TBL] [Abstract][Full Text] [Related]
6. Structure of REV-ERBβ ligand-binding domain bound to a porphyrin antagonist.
Matta-Camacho E; Banerjee S; Hughes TS; Solt LA; Wang Y; Burris TP; Kojetin DJ
J Biol Chem; 2014 Jul; 289(29):20054-66. PubMed ID: 24872411
[TBL] [Abstract][Full Text] [Related]
7. A zinc finger HIT domain-containing protein, ZNHIT-1, interacts with orphan nuclear hormone receptor Rev-erbbeta and removes Rev-erbbeta-induced inhibition of apoCIII transcription.
Wang J; Li Y; Zhang M; Liu Z; Wu C; Yuan H; Li YY; Zhao X; Lu H
FEBS J; 2007 Oct; 274(20):5370-81. PubMed ID: 17892483
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of the human LRH-1 DBD-DNA complex reveals Ftz-F1 domain positioning is required for receptor activity.
Solomon IH; Hager JM; Safi R; McDonnell DP; Redinbo MR; Ortlund EA
J Mol Biol; 2005 Dec; 354(5):1091-102. PubMed ID: 16289203
[TBL] [Abstract][Full Text] [Related]
9. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers.
Vivat V; Zechel C; Wurtz JM; Bourguet W; Kagechika H; Umemiya H; Shudo K; Moras D; Gronemeyer H; Chambon P
EMBO J; 1997 Sep; 16(18):5697-709. PubMed ID: 9312028
[TBL] [Abstract][Full Text] [Related]
10. High Affinity Heme Binding to a Heme Regulatory Motif on the Nuclear Receptor Rev-erbβ Leads to Its Degradation and Indirectly Regulates Its Interaction with Nuclear Receptor Corepressor.
Carter EL; Gupta N; Ragsdale SW
J Biol Chem; 2016 Jan; 291(5):2196-222. PubMed ID: 26670607
[TBL] [Abstract][Full Text] [Related]
11. Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta.
Raghuram S; Stayrook KR; Huang P; Rogers PM; Nosie AK; McClure DB; Burris LL; Khorasanizadeh S; Burris TP; Rastinejad F
Nat Struct Mol Biol; 2007 Dec; 14(12):1207-13. PubMed ID: 18037887
[TBL] [Abstract][Full Text] [Related]
12. Molecular dynamics simulations of human LRH-1: the impact of ligand binding in a constitutively active nuclear receptor.
Burendahl S; Treuter E; Nilsson L
Biochemistry; 2008 May; 47(18):5205-15. PubMed ID: 18410128
[TBL] [Abstract][Full Text] [Related]
13. A specific and unusual nuclear localization signal in the DNA binding domain of the Rev-erb orphan receptors.
Chopin-Delannoy S; Thénot S; Delaunay F; Buisine E; Begue A; Duterque-Coquillaud M; Laudet V
J Mol Endocrinol; 2003 Apr; 30(2):197-211. PubMed ID: 12683943
[TBL] [Abstract][Full Text] [Related]
14. Conformational adaptation of nuclear receptor ligand binding domains to agonists: potential for novel approaches to ligand design.
Togashi M; Borngraeber S; Sandler B; Fletterick RJ; Webb P; Baxter JD
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):127-37. PubMed ID: 15860255
[TBL] [Abstract][Full Text] [Related]
15. The structural basis of gas-responsive transcription by the human nuclear hormone receptor REV-ERBbeta.
Pardee KI; Xu X; Reinking J; Schuetz A; Dong A; Liu S; Zhang R; Tiefenbach J; Lajoie G; Plotnikov AN; Botchkarev A; Krause HM; Edwards A
PLoS Biol; 2009 Feb; 7(2):e43. PubMed ID: 19243223
[TBL] [Abstract][Full Text] [Related]
16. Orphan nuclear receptors adopted by crystallography.
Ingraham HA; Redinbo MR
Curr Opin Struct Biol; 2005 Dec; 15(6):708-15. PubMed ID: 16263271
[TBL] [Abstract][Full Text] [Related]
17. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma.
Nolte RT; Wisely GB; Westin S; Cobb JE; Lambert MH; Kurokawa R; Rosenfeld MG; Willson TM; Glass CK; Milburn MV
Nature; 1998 Sep; 395(6698):137-43. PubMed ID: 9744270
[TBL] [Abstract][Full Text] [Related]
18. The heme-regulatory motif of nuclear receptor Rev-erbβ is a key mediator of heme and redox signaling in circadian rhythm maintenance and metabolism.
Carter EL; Ramirez Y; Ragsdale SW
J Biol Chem; 2017 Jul; 292(27):11280-11299. PubMed ID: 28500133
[TBL] [Abstract][Full Text] [Related]
19. Structural features involved in the formation of a complex between the monomeric or the dimeric form of the rev-erb beta DNA-binding domain and its DNA reactive sites.
Terenzi H; Alzari PM; Zakin MM
Biochemistry; 1998 Aug; 37(33):11488-95. PubMed ID: 9708984
[TBL] [Abstract][Full Text] [Related]
20. Ligand-induced stabilization of PPARgamma monitored by NMR spectroscopy: implications for nuclear receptor activation.
Johnson BA; Wilson EM; Li Y; Moller DE; Smith RG; Zhou G
J Mol Biol; 2000 Apr; 298(2):187-94. PubMed ID: 10764590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
